I videoen kan du få mere information om Ritzaus distribution til de danske nyhedsmedier.
Healthcare Innovations Expo is a Perfect Platform for Synexus
Synexus, a world leader in the recruitment and running of clinical trials, will join a host of top global companies at the Healthcare Innovations Expo to be held at ExCel in London on June 18 -19.
The Expo is a platform for organisations involved in all aspects of healthcare to showcase their contribution to healthcare innovation and to stimulate better diffusion of innovation across and throughout the NHS.
Michael Fort, Synexus CEO is looking forward to the opportunity to explain the success his company is achieving in the clinical trials sector: “We are very keen to drive up the UK’s participation in global clinical trials and are already helping make this happen through our close work with PCTs and GPs, but much more needs to be done. Over the past few years overall UK involvement in global clinical trials has declined whilst at Synexus we have managed to increase patient visits by 50% in 2008 alone. We are happy to work more closely with the Department of Health on re-gaining the UK’s position as a leader in clinical trials. Our clinical trials model, which is really changing the way trials are done is an example of innovation which could be expanded.”
Synexus works with pharma, biotechs and CROs and has a network of wholly owned and dedicated clinical trial sites in the UK, Central and Eastern Europe as well as in India and South Africa. The company currently has more than 14,000 patients enrolled onto clinical trials programmes across a range of therapeutic areas.
For more information please go to: www.synexus.com
Synexus® background
Synexus® headquartered in Manchester, England, is the world’s largest multi-national company dedicated to the recruitment of clinical trials at its own research centres across the globe on behalf of its pharmaceutical, biotech and CRO clients. Synexus has 16 research centres across the UK, Poland, Hungary, Bulgaria, India and South Africa staffed by full time GCP trained investigators.
Synexus® currently has more than twelve thousand patients enrolled in clinical trials.
Contact:
Vane Percy & Roberts for Synexus Simon Vane Percy Office: +44 (0) 1737 821890 Mobile: +44 (0) 7710 005910 Home: +44 (0) 1883 724505
